impact

WEEKLY COVID VACCINE RESEARCH UPDATE FRIDAY, MARCH 26, 2021 Data Updates High-income country confirmed dose total: 4.6 billion Upper-middle-income country total: 1.5 billion Lower-middle-income country total: 711 million Low-income country total: 670 million COVAX total: 1.12 billion Total worldwide confirmed purchases of Covid-19 vaccines: 8.6 billion doses Weekly Insights and Interesting Trends Will India’s export controls doom supply for low- and middle-income countries? Author: Andrea Taylor India’s announcement this week that it would halt exports of domestically produced Covid-19 vaccines in the short term seemed to take the world by surprise. It probably shouldn’t have. For months, India’s Covid-19 cases appeared to plateau. As wealthier countries dithered about donations and paused exports, India led the way on donations and was lauded for their significant part in supplying COVAX and lower-income countries. The Serum Institute of India…

WEEKLY COVID VACCINE RESEARCH UPDATE TUESDAY, MARCH 9, 2021 Data Updates High-income country confirmed dose total: 4.6 billion Upper-middle-income country total: 1.3 billion Lower-middle-income country total: 608 million Low-income country total: 670 million COVAX total: 1.12 billion Total worldwide confirmed purchases of Covid-19 vaccines: 14.7 billion doses Weekly Insights and Interesting Trends Author: Andrea Taylor COVID-19 vaccines are flowing into the private sector. What does this mean for equity? While the vast majority of Covid-19 purchases have been through the public sector, we have also seen some private sector deals. This appears to be increasing recently, as governments are partnering with private sector health providers to widen the reach of their vaccine rollouts. Back in 2020, the Russian Direct Investment Fund (RDIF) was selling Sputnik V to private companies and…